ARTICLE | Company News
Structural Bioinformatics other research news
January 24, 2000 8:00 AM UTC
The company said it has identified several IL-5 receptor antagonist small molecules, which it is optimizing as potential lead compounds to treat asthma and other allergic diseases. The company said th...